HUTCHMED (China) (HMDCF) Shares Outstanding (Weighted Average) (2014 - 2025)

HUTCHMED (China) (HMDCF) reported Shares Outstanding (Weighted Average) of $110.4 million for Q4 2025, little changed year-over-year from $110.0 million in Q4 2024, and up 20821449.98% quarter-over-quarter from $530.0 in Q2 2025.

HUTCHMED (China) (HMDCF) Shares Outstanding (Weighted Average) (2014 - 2025) Analysis & Trends

HUTCHMED (China) (HMDCF) has 12 years of Shares Outstanding (Weighted Average) data on file, last reported at $110.4 million in Q4 2025.

  • Shares Outstanding (Weighted Average) for Q4 2025 came in at $110.4 million, changed 0.3% year-over-year; the trailing twelve-month figure through Dec 2025 was $110.4 million (changed 0.3% YoY), and the FY2025 annual result was $110.4 million, changed 0.3% from the prior year.
  • Shares Outstanding (Weighted Average) climbed to $110.4 million in Q4 2025 per HMDCF's latest filing, from $530.0 in the prior quarter.
  • Over five years, Shares Outstanding (Weighted Average) peaked at $110.4 million in Q4 2025 and troughed at $30.0 in Q2 2024.
  • A 5-year average of $61.2 million and a median of $87.3 million in 2021 frame the typical range for Shares Outstanding (Weighted Average).
  • The sharpest annual moves came in 2021 and 2025: Shares Outstanding (Weighted Average) sank 89.35% in 2021, then surged 1666.67% in 2025.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $101.8 million in 2021, then climbed by 6.42% to $108.3 million in 2022, then increased by 0.41% to $108.7 million in 2023, then gained by 1.18% to $110.0 million in 2024, then gained by 0.3% to $110.4 million in 2025.
  • Business Quant data shows HMDCF's Shares Outstanding (Weighted Average) at $110.4 million in Q4 2025, $530.0 in Q2 2025, and $110.0 million in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Weighted Avg.) (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn 1.16 Bn
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn 422.10 Mn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn 43.50 Mn
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn 5.02 Bn
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn 100.50 Mn
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn 497.70 Mn
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn 166.20 Mn
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn 64.74 Mn
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn 228.36 Mn
10 HUTCHMED (China) - - - 110.35 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 110.35 Mn
Jun 30, 2025 530.00
Dec 31, 2024 110.02 Mn
Jun 30, 2024 30.00
Dec 31, 2023 108.74 Mn
Jun 30, 2023 200.00
Dec 31, 2022 108.30 Mn
Dec 31, 2021 101.76 Mn
Jun 30, 2021 140.00
Mar 31, 2021 72.81 Mn
Dec 31, 2020 72.77 Mn
Jun 30, 2020 70.00
Mar 31, 2020 683.86 Mn
Sep 30, 2019 110.00
Jun 30, 2019 70.00
Mar 31, 2019 30.00
Dec 31, 2018 664.26 Mn
Sep 30, 2018 90.00
Jun 30, 2018 50.00
Mar 31, 2018 20.00